Myovant Sciences Ltd. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Myovant Sciences Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q4 2022.
  • Myovant Sciences Ltd. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$57.6M, a 9.17% increase year-over-year.
  • Myovant Sciences Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$184M, a 19.4% increase year-over-year.
  • Myovant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2021 was -$206M, a 19.3% increase from 2020.
  • Myovant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2020 was -$255M, a 11.7% increase from 2019.
  • Myovant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2019 was -$289M, a 5.64% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$184M -$57.6M +$5.82M +9.17% Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-26
Q3 2022 -$190M -$45.6M -$24M -111% Jul 1, 2022 Sep 30, 2022 10-Q 2023-01-26
Q2 2022 -$166M -$21.2M +$40.4M +65.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-01-26
Q1 2022 -$206M -$59.3M +$22.1M +27.1% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-11
Q4 2021 -$228M -$63.4M +$10.4M +14.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-26
Q3 2021 -$238M -$21.6M +$45.5M +67.8% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-26
Q2 2021 -$284M -$61.7M -$28.8M -87.6% Apr 1, 2021 Jun 30, 2021 10-Q 2023-01-26
Q1 2021 -$255M -$81.4M -$16.5M -25.3% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-11
Q4 2020 -$239M -$73.8M +$11.8M +13.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-26
Q3 2020 -$250M -$67.1M +$3.51M +4.97% Jul 1, 2020 Sep 30, 2020 10-Q 2022-01-26
Q2 2020 -$254M -$32.9M +$35M +51.6% Apr 1, 2020 Jun 30, 2020 10-Q 2022-01-26
Q1 2020 -$289M -$64.9M +$10.1M +13.5% Jan 1, 2020 Mar 31, 2020 10-K 2020-05-18
Q4 2019 -$299M -$85.6M -$15M -21.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$284M -$70.6M -$4.8M -7.3% Jul 1, 2019 Sep 30, 2019 10-Q 2021-02-11
Q2 2019 -$279M -$67.9M -$5.77M -9.29% Apr 1, 2019 Jun 30, 2019 10-Q 2021-02-11
Q1 2019 -$274M -$75M -$26.8M -55.5% Jan 1, 2019 Mar 31, 2019 10-K 2020-05-18
Q4 2018 -$247M -$70.6M -$28.9M -69.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-18
Q3 2018 -$218M -$65.8M -$35.9M -120% Jul 1, 2018 Sep 30, 2018 10-K 2020-05-18
Q2 2018 -$182M -$62.1M -$38.8M -166% Apr 1, 2018 Jun 30, 2018 10-K 2020-05-18
Q1 2018 -$143M -$48.3M -$26.6M -123% Jan 1, 2018 Mar 31, 2018 10-K 2019-05-24
Q4 2017 -$117M -$41.8M -$33.7M -417% Oct 1, 2017 Dec 31, 2017 10-K 2019-05-24
Q3 2017 -$83M -$29.9M +$4.8M +13.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-05-24
Q2 2017 -$87.8M -$23.3M -$4.35M -22.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-05-24
Q1 2017 -$83.4M -$21.7M -$20M -1208% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-07
Q4 2016 -$63.4M -$8.08M Oct 1, 2016 Dec 31, 2016 10-K 2018-06-07
Q3 2016 -$34.7M Jul 1, 2016 Sep 30, 2016 10-K 2018-06-07
Q2 2016 -$19M Apr 1, 2016 Jun 30, 2016 10-K 2018-06-07
Q1 2016 -$1.66M Feb 3, 2016 Mar 31, 2016 10-K 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.